Market Research Logo

Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review

Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead product candidate Syndros (dronabinol oral solution) is intendedfor the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in patients with AIDS. Insys uses its proprietary sublingual spray technology to develop its products. The company offers its products to oncologists, pain specialists and supportive care centers. It has operations in the US and offers its products through third party agreements in international markets. Insys is headquartered in Chandler, Arizona, the US.

Insys Therapeutics Inc Key Recent Developments

Mar 08,2018: INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results
Mar 01,2018: INSYS Therapeutics Confirms Completion of Founder’s Independent Trust
Feb 09,2018: INSYS Therapeutics Addresses Maryland Attorney General’s Motion
Feb 01,2018: INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors
Jan 30,2018: INSYS Therapeutics Announces Senior Management Changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Insys Therapeutics Inc - Key Facts
Insys Therapeutics Inc - Key Employees
Insys Therapeutics Inc - Key Employee Biographies
Insys Therapeutics Inc - Major Products and Services
Insys Therapeutics Inc - History
Insys Therapeutics Inc - Company Statement
Insys Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Insys Therapeutics Inc - Business Description
Insys Therapeutics Inc - Corporate Strategy
Insys Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Insys Therapeutics Inc - Strengths
Insys Therapeutics Inc - Weaknesses
Insys Therapeutics Inc - Opportunities
Insys Therapeutics Inc - Threats
Insys Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Insys Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 08, 2018: INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results
Mar 01, 2018: INSYS Therapeutics Confirms Completion of Founder’s Independent Trust
Feb 09, 2018: INSYS Therapeutics Addresses Maryland Attorney General’s Motion
Feb 01, 2018: INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors
Nov 02, 2017: INSYS Therapeutics Reports Third Quarter 2017 Results
Oct 29, 2017: INSYS Therapeutics Announces Resignation of Patrick P. Fourteau from Board of Directors
Oct 29, 2017: INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors
Oct 29, 2017: INSYS Therapeutics to Record a Minimum Liability for Department of Justice Settlement in Q3 2017
Sep 21, 2017: INSYS Therapeutics Hires First Corporate Communications Leader and New Investor Relations Agency
Aug 03, 2017: Insys Therapeutics Reports Second Quarter 2017 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Insys Therapeutics Inc, Key Facts
Insys Therapeutics Inc, Key Employees
Insys Therapeutics Inc, Key Employee Biographies
Insys Therapeutics Inc, Major Products and Services
Insys Therapeutics Inc, History
Insys Therapeutics Inc, Other Locations
Insys Therapeutics Inc, Subsidiaries
Insys Therapeutics Inc, Key Competitors
Insys Therapeutics Inc, Ratios based on current share price
Insys Therapeutics Inc, Annual Ratios
Insys Therapeutics Inc, Annual Ratios (Cont...1)
Insys Therapeutics Inc, Annual Ratios (Cont...2)
Insys Therapeutics Inc, Interim Ratios
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Insys Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Insys Therapeutics Inc, Performance Chart (2013 - 2017)
Insys Therapeutics Inc, Ratio Charts
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report